Pluri Inc. Preferred Stock, Shares Authorized
Pluri Inc. (PLUR) had Preferred Stock, Shares Authorized of 1.00 million shares as of 2023-05-01, per its 10-K filed 2024-09-18.
Discontinued › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesAuthorized · last filed 2024-09-18
- 2023-05-01: Preferred Stock, Shares Authorized 1.00M shares.
- 2022-06-30: Preferred Stock, Shares Authorized 1.00M shares.
- 2021-06-30: Preferred Stock, Shares Authorized 1.00M shares.
- 2020-06-30: Preferred Stock, Shares Authorized 1.00M shares.
| Period end | Preferred Stock, Shares Authorized |
|---|---|
| 2023-05-01 | 1.00M shares 10-K · filed 2024-09-18 |
| 2022-06-30 | 1.00M shares 10-K · filed 2022-09-21 |
| 2021-06-30 | 1.00M shares 10-K · filed 2021-09-13 |
| 2020-06-30 | 1.00M shares 10-K · filed 2020-09-10 |
| 2019-06-30 | 1.00M shares 10-K · filed 2019-09-12 |
| 2018-06-30 | 10.00M shares 10-K · filed 2018-09-12 |
| 2017-06-30 | 10.00M shares 10-K · filed 2017-09-07 |
| 2016-06-30 | 10.00M shares 10-K · filed 2016-09-07 |
| 2015-06-30 | 10.00M shares 10-K · filed 2015-09-09 |
| 2014-06-30 | 10.00M shares 10-K · filed 2014-09-11 |
| 2013-06-30 | 10.00M shares 10-K · filed 2013-09-11 |
| 2012-06-30 | 10.00M shares 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |